SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-12-11 18:18
Tx date 2023-12-11 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
Warrants
97 - Other
-1,000,000 vol 		3,845,072
Filed 2023-11-29 12:07
Tx date 2023-11-20 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption 		$
+$325,000 vol
$899.50 each 		$325,000
Filed 2023-11-29 11:45
Tx date 2023-05-24 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
Warrants
53 - Grant of warrants
+4,845,072 vol 		4,845,072
Filed 2023-11-29 11:44
Tx date 2023-11-20 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption 		$
+$325,000 vol
$899.50 each 		$325,000
Filed 2023-11-29 11:44
Tx date 2023-11-20 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption 		$
+$325,000 vol
$899.50 each
Filed 2023-11-23 14:20
Tx date 2023-11-20 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption 		$
+$325 vol
$899.50 each
Filed 2023-11-23 14:20
Tx date 2023-11-20 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption 		$
+$325 vol
$899.50 each
Filed 2023-05-24 12:18
Tx date 2023-05-24 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
Warrants
53 - Grant of warrants
+5,062,016 vol
Filed 2023-11-23 14:20
Tx date 2023-11-20 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption 		$
+$325 vol
$899.50 each 		$325
Filed 2023-11-23 14:18
Tx date 2023-10-01 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
00 - Opening Balance-Initial SEDI Report
Filed 2023-11-03 15:35
Tx date 2023-10-30 		$TRYP
Tryp Therapeutics Inc. 		Gilligan, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$216,000
+2,000,000 vol
$0.108 each 		5,769,684
Filed 2023-11-03 15:34
Tx date 2023-10-30 		$TRYP
Tryp Therapeutics Inc. 		Molloy, Peter Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$81,000
+750,000 vol
$0.108 each 		2,350,000
Filed 2023-10-31 13:50
Tx date 2023-10-30 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$833,063
+7,713,548 vol
$0.108 each 		7,713,548
Filed 2023-10-31 13:49
Tx date 2023-10-01 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-10-11 18:36
Tx date 2023-10-11 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$175,000 vol
$1,000 each 		$175,000
Filed 2023-10-11 18:24
Tx date 2023-10-01 		$TRYP
Tryp Therapeutics Inc. 		Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2023-05-24 12:24
Tx date 2023-04-26 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$1,200,000 vol
$1,000 each 		$1,200,000
Filed 2023-05-24 12:18
Tx date 2023-05-24 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
Warrants
53 - Grant of warrants
+5,062,016 vol 		5,062,016
Filed 2023-05-24 12:14
Tx date 2022-05-16 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2023-05-24 12:11
Tx date 2023-04-26 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$100,000 vol
$1,000 each 		$100,000
Filed 2023-05-01 13:52
Tx date 2023-04-26 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$1,200 vol
$1,000 each
Filed 2023-05-01 13:35
Tx date 2023-04-27 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$100 vol
$1,000 each
Filed 2023-05-01 13:52
Tx date 2023-04-26 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$1,200 vol
$1,000 each 		$1,200
Filed 2023-05-01 13:51
Tx date 2019-09-24 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2023-05-01 13:35
Tx date 2023-04-27 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$100 vol
$1,000 each 		$100
Filed 2023-05-01 13:29
Tx date 2022-05-16 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2022-10-25 15:42
Tx date 2022-10-19 		$TRYP
Tryp Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$33.42
+191 vol
$0.175 each 		463,829
Filed 2022-10-25 15:42
Tx date 2022-10-19 		$TRYP
Tryp Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,198
+38,738 vol
$0.16 each 		463,638
Filed 2022-10-25 15:41
Tx date 2022-10-11 		$TRYP
Tryp Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,161
+32,500 vol
$0.1588 each 		424,900
Filed 2022-09-19 11:06
Tx date 2022-09-16 		$TRYP
Tryp Therapeutics Inc. 		O'Neill, James
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		500,000
Filed 2022-09-08 16:47
Tx date 2022-06-14 		$TRYP
Tryp Therapeutics Inc. 		Taubenfeld, Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$374,000
+2,200,000 vol
$0.17 each
Filed 2022-09-08 16:47
Tx date 2022-06-14 		$TRYP
Tryp Therapeutics Inc. 		Taubenfeld, Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		2,200,000
Filed 2022-06-24 14:02
Tx date 2022-06-14 		$TRYP
Tryp Therapeutics Inc. 		Taubenfeld, Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$374,000
+2,200,000 vol
$0.17 each
Filed 2022-06-24 14:02
Tx date 2022-06-14 		$TRYP
Tryp Therapeutics Inc. 		Taubenfeld, Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-06-24 14:02
Tx date 2022-06-14 		$TRYP
Tryp Therapeutics Inc. 		Taubenfeld, Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$374,000
+2,200,000 vol
$0.17 each 		2,200,000
Filed 2022-06-24 14:02
Tx date 2022-06-14 		$TRYP
Tryp Therapeutics Inc. 		Taubenfeld, Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-06-19 18:54
Tx date 2022-06-14 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$136,000
+800,000 vol
$0.17 each 		800,000
Filed 2022-06-19 18:52
Tx date 2022-05-16 		$TRYP
Tryp Therapeutics Inc. 		Ntoumenopoulos, Christopher
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-26 13:47
Tx date 2022-05-22 		$TRYP
Tryp Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$136,000
+800,000 vol
$0.17 each 		2,800,000
Filed 2022-05-26 13:46
Tx date 2022-05-22 		$TRYP
Tryp Therapeutics Inc. 		Kuo, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,000
+200,000 vol
$0.17 each 		600,000
Filed 2022-05-26 13:45
Tx date 2022-05-22 		$TRYP
Tryp Therapeutics Inc. 		Molloy, Peter Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$136,000
+800,000 vol
$0.17 each 		1,600,000
Filed 2022-04-26 13:38
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Kuo, James
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-200,000 vol 		400,000
Filed 2022-04-26 13:37
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Molloy, Peter Robert
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-800,000 vol 		800,000
Filed 2022-04-26 13:36
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-800,000 vol 		2,000,000
Filed 2022-04-25 13:57
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Gilligan, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$170,000
+1,000,000 vol
$0.17 each 		3,769,684
Filed 2022-04-25 13:56
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Kuo, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$68,000
+400,000 vol
$0.17 each 		600,000
Filed 2022-04-25 13:55
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Tousley, David L
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$136,000
+800,000 vol
$0.17 each 		800,000
Filed 2022-04-25 13:54
Tx date 2022-02-18 		$TRYP
Tryp Therapeutics Inc. 		Tousley, David L
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-25 13:53
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Molloy, Peter Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$136,000
+800,000 vol
$0.17 each 		1,600,000
Filed 2022-04-25 13:52
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$340,000
+2,000,000 vol
$0.17 each 		2,800,000
Filed 2022-04-25 13:33
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$3,000,000
+20,000,000 vol
$0.15 each 		38,420,000
Filed 2022-04-25 13:32
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+10,000,000 vol 		10,000,000
Filed 2022-04-25 13:30
Tx date 2019-09-24 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-25 13:27
Tx date 2022-04-22 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,000,000
+20,000,000 vol
$0.15 each
Filed 2022-02-22 13:47
Tx date 2022-02-22 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,000,000
+5,000,000 vol
$0.20 each 		18,420,000
Filed 2021-10-27 16:25
Tx date 2021-10-25 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,534
+5,000 vol
$0.3068 each 		13,400,000
Filed 2021-10-27 10:44
Tx date 2021-10-26 		$TRYP
Tryp Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,729
+20,000 vol
$0.2865 each 		13,415,000
Filed 2021-09-01 16:22
Tx date 2021-08-31 		$TRYP
TRYP Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$450,000
+600,000 vol
$0.75 each 		800,000
Filed 2021-09-01 16:21
Tx date 2021-08-31 		$TRYP
TRYP Therapeutics Inc. 		Molloy, Peter Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$450,000
+600,000 vol
$0.75 each 		800,000
Filed 2021-08-26 14:18
Tx date 2021-08-25 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,516
+28,500 vol
$0.369 each 		13,395,000
Filed 2021-08-26 14:18
Tx date 2021-08-25 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$540.00
+1,500 vol
$0.36 each 		13,366,500
Filed 2021-08-26 14:17
Tx date 2021-08-25 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$356.20
+1,000 vol
$0.3562 each 		13,365,000
Filed 2021-08-26 14:17
Tx date 2021-08-25 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$900.25
+2,500 vol
$0.3601 each 		13,364,000
Filed 2021-08-26 14:15
Tx date 2021-08-25 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,371
+17,500 vol
$0.3641 each 		13,361,500
Filed 2021-08-26 14:15
Tx date 2021-08-25 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$926.00
+2,500 vol
$0.3704 each 		13,344,000
Filed 2021-08-26 14:14
Tx date 2021-08-25 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$930.00
+2,500 vol
$0.372 each 		13,341,500
Filed 2021-08-26 14:14
Tx date 2021-08-25 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,560
+4,000 vol
$0.39 each 		13,339,000
Filed 2021-08-26 14:13
Tx date 2021-08-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,552
+4,500 vol
$0.3451 each 		13,335,000
Filed 2021-08-26 14:13
Tx date 2021-08-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,051
+14,500 vol
$0.3484 each 		13,330,500
Filed 2021-08-26 14:12
Tx date 2021-08-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$352.20
+1,000 vol
$0.3522 each 		13,316,000
Filed 2021-08-26 14:11
Tx date 2021-08-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,571
+4,500 vol
$0.3493 each 		13,315,000
Filed 2021-08-26 14:11
Tx date 2021-08-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,509
+10,000 vol
$0.3509 each 		13,310,500
Filed 2021-08-26 14:10
Tx date 2021-08-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,108
+25,500 vol
$0.3572 each 		13,300,500
Filed 2021-08-26 14:10
Tx date 2021-08-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$11,640
+34,500 vol
$0.3374 each 		13,275,000
Filed 2021-08-26 14:09
Tx date 2021-08-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,473
+30,000 vol
$0.3491 each 		13,240,500
Filed 2021-04-01 19:19
Tx date 2021-04-01 		$TRYP
TRYP Therapeutics Inc. 		Kuo, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$136,000
+200,000 vol
$0.68 each 		200,000
Filed 2021-04-01 19:18
Tx date 2019-09-24 		$TRYP
TRYP Therapeutics Inc. 		Kuo, James
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-04-01 16:10
Tx date 2021-03-31 		$TRYP
TRYP Therapeutics Inc. 		McKee, Gregory Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,564,000
+2,300,000 vol
$0.68 each 		4,500,000
Filed 2021-03-15 17:13
Tx date 2021-03-08 		$TRYP
TRYP Therapeutics Inc. 		Hayes, Luke James
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		1,500,000
Filed 2021-02-03 15:25
Tx date 2021-02-03 		$TRYP
TRYP Therapeutics Inc. 		McKee, Gregory Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,400,000
+2,000,000 vol
$0.70 each 		2,200,000
Filed 2021-02-03 15:24
Tx date 2021-01-13 		$TRYP
TRYP Therapeutics Inc. 		McKee, Gregory Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$150,000
+200,000 vol
$0.75 each 		200,000
Filed 2021-02-03 15:23
Tx date 2021-01-13 		$TRYP
TRYP Therapeutics Inc. 		McKee, Gregory Mark
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-03 15:22
Tx date 2021-01-13 		$TRYP
TRYP Therapeutics Inc. 		McKee, Gregory Mark
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-03 15:13
Tx date 2021-01-13 		$TRYP
TRYP Therapeutics Inc. 		McKee, Gregory Mark
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-28 17:11
Tx date 2021-01-28 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,973
+10,500 vol
$0.4737 each 		13,210,500
Filed 2021-01-13 17:27
Tx date 2020-09-25 		$TRYP
TRYP Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+392,400 vol 		392,400
Filed 2021-01-13 17:25
Tx date 2019-09-24 		$TRYP
TRYP Therapeutics Inc. 		Kuo, James
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+6,000,000 vol 		6,000,000
Filed 2020-12-15 13:48
Tx date 2019-09-24 		$TRYP
TRYP Therapeutics Inc. 		Kuo, James
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+6,000,000 vol
Filed 2020-12-14 16:38
Tx date 2020-09-25 		$TRYP
TRYP Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+392,400 vol
Filed 2021-01-08 17:03
Tx date 2019-09-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		13,200,000
Filed 2021-01-08 16:47
Tx date 2020-06-30 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+13,147,200 vol
Filed 2021-01-08 16:46
Tx date 2020-06-23 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-13,147,200 vol
Filed 2021-01-08 16:46
Tx date 2020-01-09 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
+13,134,000 vol
Filed 2021-01-08 16:46
Tx date 2020-01-09 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+26,000 vol
Filed 2021-01-08 16:46
Tx date 2020-01-09 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+40,000 vol
Filed 2020-12-09 19:23
Tx date 2020-06-30 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+13,147,200 vol
Filed 2020-12-09 19:23
Tx date 2020-06-23 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-13,147,200 vol
Filed 2020-12-09 19:21
Tx date 2020-01-09 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
+13,134,000 vol
Filed 2020-12-09 19:16
Tx date 2020-01-09 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+26,000 vol
Filed 2020-12-09 19:12
Tx date 2020-01-29 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+26,000 vol
Filed 2020-12-09 19:12
Tx date 2020-01-09 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+40,000 vol
Filed 2020-12-09 19:09
Tx date 2019-09-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-30 14:01
Tx date 2020-12-22 		$TRYP
TRYP Therapeutics Inc. 		Molloy, Peter Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$150,000
+200,000 vol
$0.75 each 		200,000
Filed 2020-12-30 13:59
Tx date 2020-09-30 		$TRYP
TRYP Therapeutics Inc. 		Molloy, Peter Robert
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-29 17:50
Tx date 2020-12-22 		$TRYP
TRYP Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$150,000
+200,000 vol
$0.75 each 		200,000
Filed 2020-12-29 17:43
Tx date 2020-09-25 		$TRYP
TRYP Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-15 13:48
Tx date 2019-09-24 		$TRYP
TRYP Therapeutics Inc. 		Kuo, James
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+6,000,000 vol 		6,000,000
Filed 2020-12-15 13:47
Tx date 2019-09-24 		$TRYP
TRYP Therapeutics Inc. 		Kuo, James
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-14 16:38
Tx date 2020-09-25 		$TRYP
TRYP Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+392,400 vol 		392,400
Filed 2020-12-14 16:38
Tx date 2020-09-25 		$TRYP
TRYP Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-14 16:37
Tx date 2020-09-25 		$TRYP
TRYP Therapeutics Inc. 		Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-09 19:23
Tx date 2020-06-30 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+13,147,200 vol 		13,200,000
Filed 2020-12-09 19:23
Tx date 2020-06-23 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-13,147,200 vol 		52,800
Filed 2020-12-09 19:21
Tx date 2020-01-09 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
+13,134,000 vol 		13,200,000
Filed 2020-12-09 19:16
Tx date 2020-01-09 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+26,000 vol 		66,000
Filed 2020-12-09 19:12
Tx date 2020-01-29 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+26,000 vol
Filed 2020-12-09 19:12
Tx date 2020-01-09 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+40,000 vol 		40,000
Filed 2020-12-09 19:09
Tx date 2019-09-24 		$TRYP
TRYP Therapeutics Inc. 		Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-09 13:23
Tx date 2020-12-08 		$TRYP
TRYP Therapeutics Inc. 		Gieselman, Terese
5 - Senior Officer of Issuer
Holder: Minco Corporate Management Inc (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		500,000
Filed 2020-12-09 13:10
Tx date 2020-12-08 		$TRYP
TRYP Therapeutics Inc. 		Gilligan, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
Options
15 - Acquisition or disposition under a prospectus
+2,769,684 vol 		2,769,684
Filed 2020-12-09 13:09
Tx date 2020-11-02 		$TRYP
TRYP Therapeutics Inc. 		Gilligan, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-03 18:38
Tx date 2020-09-30 		$TRYP
TRYP Therapeutics Inc. 		Molloy, Peter Robert
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		200,000